This chapter explores the reasons behind the absence of a Lyme disease vaccine and the potential for a new vaccine in the future. It discusses the failed Lyme vaccine from 1998, the current phase three trials for a new vaccine, and the challenges of vaccine skepticism. The chapter also highlights a novel approach to vaccine development and the similarities between tick vaccines and products used for tick prevention in dogs.
Bloomberg News US Semiconductor & Networking Reporter Ian King and Bloomberg Intelligence Senior Semiconductor Analyst Kunjan Sobhani recap Nvidia news after the chipmaker gave a revenue forecast that was much stronger than expected on Wednesday. Splunk CEO Gary Steele talks about his company's earnings and unveiling new innovations. Dr. Andy Pekosz, Professor of Molecular Microbiology and Immunology at the Johns Hopkins University Bloomberg School of Public Health, discusses seeing a summer resurgence in Covid cases. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Health Care Reporter Kristen Brown provide the details of Kristen's Businessweek Magazine cover story The Last Lyme Shot Failed. Will a New One From Pfizer Succeed? And we Drive to the Close with Nadia Lovell, Senior US Equity Strategist at UBS Global Wealth Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.